Last reviewed · How we verify

NCT05019820

Identification of Sarcopenia in Knee Osteoarthritis With Ultrasonography and Evaluation of Muscle Architecture Change by Ultrasonography After Isokinetic Exercise Program

Status unknown Phase 4 Last updated 25 August 2021
What this trial tests

Phase 4 trial testing Knee strengthening exercises with isokinetic dynamometer in Osteoarthritis of the Knee in 60 participants. Status unknown.

Timeline
18 August 2021
Primary endpoint
20 November 2021
13 December 2022

Quick facts

Lead sponsorSema Dağcı
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment60
Start date18 August 2021
Primary completion20 November 2021
Estimated completion13 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sema Dağcı

Who can join

Adults 45 to 65, female only, with Osteoarthritis of the Knee or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this thesis; To define sarcopenia in knee osteoarthritis with ultrasonography and to evaluate changes in muscle structure in sarcopenia after isokinetic exercise application ultrasonographically. The investigators will evaluate the effect of isokinetic exercise therapy in sarcopenic patients with knee osteoarthritis with VAS (Visual Analog Scale) and WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index). Then, the hand grip strength will be evaluated with a dynamometer, and its effects on physical performance will be evaluated by 6 meters walking and chair rising tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis of the Knee

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05019820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing